Your new experience awaits. Try the new design now and help us make it even better

CLINICAL TRIAL article

Front. Neurol.

Sec. Experimental Therapeutics

The effectiveness of Zhi-Shi plaster acupoint therapy combined with Lactulose in the Treatment of geriatrics Functional Constipation: A randomized controlled trial

Provisionally accepted
王  莹王 莹1zhang  xi xiazhang xi xia2*li  huili hui2*xia  jun quanxia jun quan2zhou  meng yanzhou meng yan1hua  yong zhihua yong zhi2*zhang  long shuzhang long shu1zhou  li rongzhou li rong1
  • 1School of Nursing, Nanjing University of Chinese Medicine, Nanjing, China
  • 2Affliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Liaoning Province, China

The final, formatted version of the article will be published soon.

Objective: This study aimed to evaluate the effectiveness and adverse effects of Zhi-Shi plaster acupoint therapy combined with Lactulose in the Treatment of geriatrics Functional Constipation. Methods: A total of 62 geriatrics Functional Constipation patients were randomly assigned to the intervention group (n=31) and control group (n=31). The intervention group received oral lactulose (20 mL daily for 14 consecutive days) plus Zhi-Shi plaster acupoint therapy (for 4 hours daily at the following acupoints: CV8, bilateral ST25, and bilateral SP15). The control group received oral lactulose plus placebo acupoint therapy during the same period. The primary outcomes included the clinical efficacy and the Constipation Symptom Scoring Scale(CSS). Secondary outcomes included the weekly count of complete spontaneous bowel movements (CSBMs), the Bristol Stool Form Scale (BSFS), the Patient Assessment of Constipation-Symptoms (PAC-SYM), the Constipation Quality of Life Scale (PAC-QOL) and adverse effects. Assessments were conducted at baseline, the week1, the week2, and the week6, with data analysis using generalized estimating equations.And the outcome assessors and statistician was blinded. Results: After treatment, The overall clinical efficacy was higher in the intervention group than in controls (96.77% vs. 83.87%, P = 0.03). The intervention group demonstrated superior improvements across outcomes compared to the control group: constipation symptoms (CSS: coefficient = -3.36, 95% CI: -4.68 to -2.03, P < 0.001), frequency of complete spontaneous bowel movements (CSBMs: coefficient = 0.59, 95% CI: 0.40 to 0.79, P < 0.001), and stool consistency (BSFS: coefficient = 0.45, 95% CI: 0.20 to 0.70, P < 0.001). Similarly, significant reductions in patient-assessed symptom severity (PAC-SYM: coefficient = -0.72, 95% CI: -0.91 to -0.52, P < 0.001) and greater enhancements in quality of life (PAC-QOL: coefficient = -0.34, 95% CI: -0.43 to -0.24, P < 0.001) were observed. Finally, the incidence of adverse reactions was lower in the intervention group (3.22% vs. 19.35%, P = 0.015). Conclusion: The combination of lactulose and Zhi-Shi plaster acupoint therapy for the treatment of geriatrics Functional Constipation can significantly improve clinical efficacy, reduce adverse effects, alleviate symptoms and enhance quality of life.

Keywords: Acupoint Therapy, Functional constipation, Elderly, Lactulose, Zhi-Shi plaster

Received: 11 Mar 2025; Accepted: 30 Oct 2025.

Copyright: © 2025 莹, xia, hui, quan, yan, zhi, shu and rong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
zhang xi xia, 543013698@qq.com
li hui, 32260890@qq.com
hua yong zhi, 13951887176@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.